I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 3 studies | 19% ± 3% | |
| type I pneumocyte | 3 studies | 23% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 3 studies | 19% ± 3% | |
| type I pneumocyte | 3 studies | 23% ± 6% |
Insufficient scRNA-seq data for expression of SLC16A5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 99% | 801.25 | 179 / 180 | 97% | 28.71 | 418 / 430 |
| intestine | 99% | 1187.52 | 959 / 966 | 96% | 26.70 | 505 / 527 |
| lung | 100% | 2573.77 | 578 / 578 | 93% | 25.62 | 1071 / 1155 |
| stomach | 96% | 952.19 | 345 / 359 | 96% | 26.94 | 274 / 286 |
| bladder | 100% | 1408.19 | 21 / 21 | 89% | 35.38 | 449 / 504 |
| uterus | 100% | 969.94 | 170 / 170 | 86% | 17.97 | 397 / 459 |
| esophagus | 91% | 546.41 | 1319 / 1445 | 93% | 31.12 | 170 / 183 |
| thymus | 100% | 1571.08 | 653 / 653 | 82% | 13.48 | 495 / 605 |
| breast | 100% | 810.73 | 457 / 459 | 81% | 16.31 | 900 / 1118 |
| skin | 100% | 1202.40 | 1809 / 1809 | 72% | 12.34 | 341 / 472 |
| pancreas | 67% | 235.91 | 220 / 328 | 92% | 35.37 | 164 / 178 |
| prostate | 100% | 1598.25 | 245 / 245 | 58% | 8.63 | 291 / 502 |
| kidney | 100% | 4870.87 | 89 / 89 | 53% | 10.12 | 478 / 901 |
| spleen | 100% | 1093.08 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 82.79 | 1 / 1 |
| adipose | 99% | 638.99 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 20.64 | 79 / 80 |
| peripheral blood | 96% | 1592.15 | 890 / 929 | 0% | 0 | 0 / 0 |
| heart | 95% | 767.68 | 822 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 444.42 | 752 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 9.88 | 38 / 45 |
| blood vessel | 74% | 258.70 | 982 / 1335 | 0% | 0 | 0 / 0 |
| liver | 37% | 118.54 | 84 / 226 | 11% | 1.92 | 44 / 406 |
| adrenal gland | 28% | 61.98 | 71 / 258 | 9% | 0.66 | 20 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 1.79 | 6 / 29 |
| brain | 6% | 17.18 | 169 / 2642 | 2% | 0.15 | 13 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015718 | Biological process | monocarboxylic acid transport |
| GO_0055085 | Biological process | transmembrane transport |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0015293 | Molecular function | symporter activity |
| GO_0008028 | Molecular function | monocarboxylic acid transmembrane transporter activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SLC16A5 |
| Protein name | Solute carrier family 16 member 5 Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5) |
| Synonyms | MCT6 MCT5 |
| Description | FUNCTION: Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity). . |
| Accessions | ENST00000538213.6 [O15375-2] ENST00000584118.1 ENST00000578376.5 ENST00000578847.5 ENST00000329783.9 [O15375-1] ENST00000584207.5 ENST00000580123.5 [O15375-1] J3KS19 J3KT93 O15375 J3QQW5 ENST00000450736.6 [O15375-1] J3QL40 |
